SOLID TUMORS, KRAS MUTATION

Clinical trials for SOLID TUMORS, KRAS MUTATION explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMORS, KRAS MUTATION trials appear

Sign up with your email to follow new studies for SOLID TUMORS, KRAS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test new pill to target 'Undruggable' cancer driver

Disease control Ongoing

This is an early safety study for adults with advanced solid tumors (like lung or colorectal cancer) that have a specific KRAS G12C mutation and have stopped responding to standard treatments. Researchers are testing a new oral drug, BI 1823911, for the first time in people, both…

Matched conditions: SOLID TUMORS, KRAS MUTATION

Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

SOLID TUMORS, KRAS MUTATION

Get alerted when new SOLID TUMORS, KRAS MUTATION trials appear

Scientists test new pill to target 'Undruggable' cancer driver